What eye care companies will be hiring in the future?

[anonymous]

NovaBay product is good but management/direction has been a continuous dumpster fire....Maybe they are finally turning things around. Who knows?

Looks like we are all in the same boat. It's really a crapshoot because all of these companies have their risks. I think that there are some good points made in this thread that don't bear repeating. Having been in eye care for over a decade, here is my opinion on which company I would go to:

Sun: Yes...depending on the RSM

Eyevance: No....I can't get into details but there are tell-tale signs that this would not be a good career move.

NovaBay: Yes....I think this company has finally got their shit together.

Kala: No.....heard from a few reps that I know very well that this is a sinking ship and tenured reps should sta away.

Novartis: Yes

Shire: No.....the reps on here and the ones I know will all tell you this.

Aerie: No........big mistake going to this company

Eyepoint: Yes

B&L: Yes......I know a lot of people who work there

Dompe: Yes

I'm curious on what everyone else thinks.

 

[anonymous]

EyePoint, so confident in their product that they went contract. Ask yourself that question. At least Kala hired a sales force. Eyevance is a sketchy outfit, think Sun on steroids, selling Alcon throwaways.

Eyepoint was a different company a year ago. their dexamethasone injection was not approved by FDA. who wants to sell that toxic drug? Injectable steroid??? Small target group. IOP increase risk not worth it.

 

[anonymous]

Looks like we are all in the same boat. It's really a crapshoot because all of these companies have their risks. I think that there are some good points made in this thread that don't bear repeating. Having been in eye care for over a decade, here is my opinion on which company I would go to:

Sun: Yes...depending on the RSM

Eyevance: No....I can't get into details but there are tell-tale signs that this would not be a good career move.

NovaBay: Yes....I think this company has finally got their shit together.

Kala: No.....heard from a few reps that I know very well that this is a sinking ship and tenured reps should sta away.

Novartis: Yes

Shire: No.....the reps on here and the ones I know will all tell you this.

Aerie: No........big mistake going to this company

Eyepoint: Yes

B&L: Yes......I know a lot of people who work there

Dompe: Yes

I'm curious on what everyone else thinks.

Eyepoint? No Way. See reply to different thread.

Kala? Heck yeah. I am a very tenured rep and this it their first foray into all different kinds of disease states. Alot of $$$

Dompe? Yes but pharma reps wont get it

 

[anonymous]

Looks like we are all in the same boat. It's really a crapshoot because all of these companies have their risks. I think that there are some good points made in this thread that don't bear repeating. Having been in eye care for over a decade, here is my opinion on which company I would go to:

Sun: Yes...depending on the RSM

Eyevance: No....I can't get into details but there are tell-tale signs that this would not be a good career move.

NovaBay: Yes....I think this company has finally got their shit together.

Kala: No.....heard from a few reps that I know very well that this is a sinking ship and tenured reps should sta away.

Novartis: Yes

Shire: No.....the reps on here and the ones I know will all tell you this.

Aerie: No........big mistake going to this company

Eyepoint: Yes

B&L: Yes......I know a lot of people who work there

Dompe: Yes

I'm curious on what everyone else thinks.

Ive talked to each of these companies. Ive turned down offers from a couple.
I would agree with this assessment and am negotiating with one now.

Can not wait to resign.

 

[anonymous]

Looks like we are all in the same boat. It's really a crapshoot because all of these companies have their risks. I think that there are some good points made in this thread that don't bear repeating. Having been in eye care for over a decade, here is my opinion on which company I would go to:

Sun: Yes...depending on the RSM

Eyevance: No....I can't get into details but there are tell-tale signs that this would not be a good career move.

NovaBay: Yes....I think this company has finally got their shit together.

Kala: No.....heard from a few reps that I know very well that this is a sinking ship and tenured reps should sta away.

Novartis: Yes

Shire: No.....the reps on here and the ones I know will all tell you this.

Aerie: No........big mistake going to this company

Eyepoint: Yes

B&L: Yes......I know a lot of people who work there

Dompe: Yes

I'm curious on what everyone else thinks.

I disagree on a few:

Sun: why would you work here when Xiidra is the better product. We all know that.

Eyepoint: only if you need a job. Why work for a contract (and don’t say everyone is on a contract) when you can sell a better product at OcularTherapuetics and be employed by the company. You won’t be fully vested in 401k with contract company for four years. You are better off staying at Shire

Kala: yes. MPP technology is a homerun. Studies show it is “statistically significant” more effective than lotemax. Plus base is significantly higher and stock options as well

 

[anonymous]

Thanks Mr Kala. Very few will use loteprednol for surgery. Just ask all the BL LOSERS. Good luck!

 

[anonymous]

I disagree on a few:

Sun: why would you work here when Xiidra is the better product. We all know that.

Eyepoint: only if you need a job. Why work for a contract (and don’t say everyone is on a contract) when you can sell a better product at OcularTherapuetics and be employed by the company. You won’t be fully vested in 401k with contract company for four years. You are better off staying at Shire

Kala: yes. MPP technology is a homerun. Studies show it is “statistically significant” more effective than lotemax. Plus base is significantly higher and stock options as well

Dompé is a yes too...they are offering A LOT more money

 

[anonymous]

I simply want out of dry eye and to sell a product docs are interested in.

 

[anonymous]

Ocular Therapeutics is a disaster. May not get approved. Product is not effective and doesn’t penetrate.

 

[anonymous]

Well, let me SEE
My VISION is of course hindSIGHTbut I would not assume just because u sell in the OBU you will even be LOOKED at by another EYE company. Shire is primary care and sucks at that too..

Judging by the constant whining on this board; all of which is coming from the OBU- it may be best to look back to where u came from; copier sales, insurance or enterprise.

 

[anonymous]

Well, let me SEE
My VISION is of course hindSIGHTbut I would not assume just because u sell in the OBU you will even be LOOKED at by another EYE company. Shire is primary care and sucks at that too..

Judging by the constant whining on this board; all of which is coming from the OBU- it may be best to look back to where u came from; copier sales, insurance or enterprise.

sad little jealous person. The OBU is one of the most experienced teams in pharma, certainly at Shire. The overwhelming majority of reps had 10 years in eye pharma sales. But you wouldn’t know, nor could you ever make it n the field.

Whining? I don’t know about that. Vocal? Yes. We left good jobs to come to this flea bag place that gave promises it never lived up to.

 

[anonymous]

Looks like we are all in the same boat. It's really a crapshoot because all of these companies have their risks. I think that there are some good points made in this thread that don't bear repeating. Having been in eye care for over a decade, here is my opinion on which company I would go to:

Sun: Yes...depending on the RSM

Eyevance: No....I can't get into details but there are tell-tale signs that this would not be a good career move.

NovaBay: Yes....I think this company has finally got their shit together.

Kala: No.....heard from a few reps that I know very well that this is a sinking ship and tenured reps should sta away.

Novartis: Yes

Shire: No.....the reps on here and the ones I know will all tell you this.

Aerie: No........big mistake going to this company

Eyepoint: Yes

B&L: Yes......I know a lot of people who work there

Dompe: Yes

I'm curious on what everyone else thinks.

Sun-no-post op nightmare
Eyevance-no-hiring tool management
Novabay-dont know
Kala-post op loteprednol nightmare, ex bandl have fun bahaaaaa
Novartis-yes
Shire-loser dry eye-nope
Aerie-more unneeded glaucoma with bad management
Eyepoint-terrible upper lower management-dumb kk proteges
B and l-are they even relevant any longer? Not!
Dompe-hear wont be able to sustane levels in drop vs prokera. Better enjoy pay if you got it.

 

[anonymous]

I say B&L yes. At least they have a huge portfolio of products and not all their eggs in one basket.

 

[anonymous]

I say B&L yes. At least they have a huge portfolio of products and not all their eggs in one basket.

Are they still owned by loser valeant? Ruined a once great American company

 

[anonymous]

Sun: No. Bad products. Worse leadership. Major turnover.

Eyevance: No. Bad products. Looking to build up and sell off.

NovaBay: Maybe - if get their IC, distribution, and mgmnt in order

Kala: Maybe - I don’t really want to sell that crap but it’s a job. More than we’ll likely have here in Spring 2019. They will have big managed care challenges.

Novartis: Yes but hear they will hire most from internal.

Shire: No.....decent product but selling one product is boring especially when it is dry eye. Offices are fatigued with Xiidra and the PAs. Disconnected leadership and pathetic managed care.

Aerie: No....poor leadership and culture. Lots of turnover in just a few months.

Eyepoint: Maybe...if they ever get off the ground. Seem to have some internal challenges. 2 products approved from FDA but can’t get them launched. Concerning.

B&L: Maybe. Multiple products. Crazy how the tide has turned and they seem more stable than most and at least are committed to the ophthalmic space and managed care contracting.

Dompe: Maybe. Hear they may have some infrastructure and manufacturing challenges.

 

[anonymous]

Sun: No. Bad products. Worse leadership. Major turnover.

Eyevance: No. Bad products. Looking to build up and sell off.

NovaBay: Maybe - if get their IC, distribution, and mgmnt in order

Kala: Maybe - I don’t really want to sell that crap but it’s a job. More than we’ll likely have here in Spring 2019. They will have big managed care challenges.

Novartis: Yes but hear they will hire most from internal.

Shire: No.....decent product but selling one product is boring especially when it is dry eye. Offices are fatigued with Xiidra and the PAs. Disconnected leadership and pathetic managed care.

Aerie: No....poor leadership and culture. Lots of turnover in just a few months.

Eyepoint: Maybe...if they ever get off the ground. Seem to have some internal challenges. 2 products approved from FDA but can’t get them launched. Concerning.

B&L: Maybe. Multiple products. Crazy how the tide has turned and they seem more stable than most and at least are committed to the ophthalmic space and managed care contracting.

Dompe: Maybe. Hear they may have some infrastructure and manufacturing challenges.

Agree. This analysis sounds about right.

 

[anonymous]

sad little jealous person. The OBU is one of the most experienced teams in pharma, certainly at Shire. The overwhelming majority of reps had 10 years in eye pharma sales. But you wouldn’t know, nor could you ever make it n the field.

Whining? I don’t know about that. Vocal? Yes. We left good jobs to come to this flea bag place that gave promises it never lived up to.

Please leave so we don't have to pay severance $s to a loser rep.

 

[anonymous]

I like this thread. Interesting takes on the different companies.

The company I know the least about is Eyevance. What's their deal? They were hiring
recently but I haven't heard a peep, good or bad.

 

[anonymous]

Eyevance has Alcon reject products and is ran by old Ista and old Sun leadership. Shady. Heard pay is low.

 

[anonymous]

Sun: No. Bad products. Worse leadership. Major turnover.

Eyevance: No. Bad products. Looking to build up and sell off.

NovaBay: Maybe - if get their IC, distribution, and mgmnt in order

Kala: Maybe - I don’t really want to sell that crap but it’s a job. More than we’ll likely have here in Spring 2019. They will have big managed care challenges.

Novartis: Yes but hear they will hire most from internal.

Shire: No.....decent product but selling one product is boring especially when it is dry eye. Offices are fatigued with Xiidra and the PAs. Disconnected leadership and pathetic managed care.

Aerie: No....poor leadership and culture. Lots of turnover in just a few months.

Eyepoint: Maybe...if they ever get off the ground. Seem to have some internal challenges. 2 products approved from FDA but can’t get them launched. Concerning.

B&L: Maybe. Multiple products. Crazy how the tide has turned and they seem more stable than most and at least are committed to the ophthalmic space and managed care contracting.

Dompe: Maybe. Hear they may have some infrastructure and manufacturing challenges.

With the exception of Novartis, which may buy us, all of these eye companies will share the fate of Aerie. Mark my counsel. I plan to stay and go with Takeda or Novartis should they bus X. Happy Holidays!